Clinical - ABL SA : ABL SA

Read more

EMRs - Registries - Integration tool

Read more

Clinical solutions

Discover our solutions

Clinical applications

Discover our applications

ABL Solutions for Coronavirus (2019-nCoV) Diagnostics

Mar 20, 2020

ABL is pleased to announce our solutions for Detection – Confirmation – Genotyping of 2019 – nCoV :
Read more
Major Updates on HIV Genotyping

Jan 15, 2020

ABL is pleased to announce two major updates on its HIV Genotyping Software applications : the full integration of the ViroScore® and DeepChek® software applications with Nadis the availability of a new web-based and disease-specific chromatogram editor
Read more
Meet ABL at MEDICA for Leveraging your Infectious Diseases Genotyping Capacities?

Oct 21, 2019

Meet us at MEDICA 2019 for Leveraging your Infectious Diseases Genotyping Capacities Good morning, ABL will be attending the next MEDICA forum in Düsseldorf from 18 – 21 November 2019 (Hall 3 / A74). We will be pleased to have a chance to meet you there and explain you in detail the SA…
Read more

TGEN AND ABL PLAN GLOBAL ROLLOUT OF ADVANCED TEST FOR TB, ONE OF THE WORLD’S MOST DEADLY PATHOGENS

Aug 01, 2019

FLAGSTAFF, Ariz., and LUXEMBOURG CITY, Luxembourg — Aug. 31 — Advanced Biological Laboratories (ABL) is expected to soon begin manufacturing of a compact, portable and affordable test for tuberculosis (TB), designed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hop…
Read more
Connexion du logiciel ViroScore®-HIV (CE IVD) à Nadis disponible

Jul 26, 2019

Nous avons le plaisir de vous annoncer que l’intégration du logiciel ViroScore®-HIV (CE IVD) à la plateforme Nadis est disponible. Cette intégration permet à l’ensemble des utilisateurs Nadis de bénéficier de fonctionnalités avancées pour le génotypage du VIH: Synchronisation bidirectionnelle des do…
Read more
ABL Announces Distribution Agreement with Hydrox SIA in Latvia

Jul 01, 2019

Advanced Biological Laboratories (ABL) S.A. and ILC – Hydrox SIA are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Latvia. See current channel partners.
Read more

Connection du logiciel ViroScore®-HIV (CE IVD) à Nadis bientôt disponible

Apr 08, 2019

Nous avons le plaisir de vous annoncer que l’intégration du logiciel ViroScore®-HIV (CE IVD) à la plateforme Nadis est bientôt disponible. Cette intégration va permettre à l’ensemble des utilisateurs Nadis de bénéficier de fonctionnalités avancées pour le génotypage du VIH telles que l…
Read more
MicrobioChek – An innovative software system for micro-organisms analysis and clinical interpretation

Mar 26, 2019

ABL is pleased to announce the development and future release of the first version of MicrobioChek, a generic downstream analysis software intended to be used by microbiology laboratories for micro-organism related molecular analysis. Developed with the support of a RDI grant from the Ministry of th…
Read more
TGen and ABL pursue global rollout of advanced TB test

Mar 19, 2019

FLAGSTAFF, Ariz., LUXEMBOURG City, Luxembourg — In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories (ABL…
Read more